AI Verdict
EPSN has stronger fundamentals based on our AI analysis.
EPSN vs EPRX Fundamental Comparison
| Metric | EPSN | EPRX |
|---|---|---|
| Revenue | $36.8M | N/A |
| Net Income | $1.1M | N/A |
| Net Margin | 2.9% | N/A |
| ROE | 1.1% | N/A |
| ROA | 0.8% | N/A |
| Current Ratio | 1.93x | N/A |
| Debt/Equity | 0.00x | N/A |
| EPS | $0.30 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EPSN vs EPRX: Frequently Asked Questions
Is EPSN or EPRX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EPSN has stronger fundamentals. EPSN is rated HOLD (65% confidence) while EPRX is rated SELL (95% confidence). This is not investment advice.
How does EPSN compare to EPRX fundamentally?
Epsilon Energy Ltd. has ROE of 1.1% vs EUPRAXIA PHARMACEUTICALS INC.'s N/A. Net margins are 2.9% vs N/A respectively.
Which stock pays higher dividends, EPSN or EPRX?
EPSN has a dividend yield of N/A or no dividend while EPRX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EPSN or EPRX for long term?
For long-term investing, consider that EPSN has HOLD rating with 65% confidence, while EPRX has SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EPSN vs EPRX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EPSN vs EPRX, the AI consensus favors EPSN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.